52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus - Drugs.com MedNews
Links shared publicly online about this topic.
- 850total visits
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus - Drugs.com MedNews
Sep 24, 2010 - Bristol-Myers Squibb Company (NYSE BMY) and AstraZeneca (NYSE AZN) today announced results from a randomized, double-blind Phase 3 clinical study
View full resource at drugs.com
Tags: Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Drug, Phase 3 Clinical Trial, Glucophage, Glucotrol
Most Recently Shared on September 24, 2010 at 1:05 pm By:
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metfo... http://bit.ly/accdmv #drug
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus | Business Wire
businesswire.com — “52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin” View full resource at businesswire.com
Most Recently Shared on September 25, 2010 at 7:53 am By:
Urology & Nephrology OW Health
52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin ... http://bit.ly/9HYgGl
Advertisement
